AAAAAA

   
Results: 1-12 |
Results: 12
EFFECT OF L-NAME, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS, ON PLASMA-LEVELS OF IL-6, IL-8, TNF-ALPHA AND NITRITE NITRATE IN HUMAN SEPTIC SHOCK/
Authors: AVONTUUR JAM STAM TC JONGENLAVRENCIC M VANAMSTERDAM JGC EGGERMONT AMM BRUINING HA
Citation: Jam. Avontuur et al., EFFECT OF L-NAME, AN INHIBITOR OF NITRIC-OXIDE SYNTHESIS, ON PLASMA-LEVELS OF IL-6, IL-8, TNF-ALPHA AND NITRITE NITRATE IN HUMAN SEPTIC SHOCK/, Intensive care medicine, 24(7), 1998, pp. 673-679
ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM WOGNUM A VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE, Journal of rheumatology, 24(8), 1997, pp. 1504-1509
EFFECTS OF ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR-ALPHA ON THE FUNCTION OF MONOCYTES AND T-LYMPHOCYTES IN PATIENTS WITH CANCER
Authors: STAM TC JONGENLAVRENCIC M EGGERMONT AMM SWAAK AJG
Citation: Tc. Stam et al., EFFECTS OF ISOLATED LIMB PERFUSION WITH TUMOR-NECROSIS-FACTOR-ALPHA ON THE FUNCTION OF MONOCYTES AND T-LYMPHOCYTES IN PATIENTS WITH CANCER, European journal of clinical investigation, 26(12), 1996, pp. 1085-1091
IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS
Authors: JONGENLAVRENCIC M PEETERS HRM ROZEMULLER H ROMBOUTS WJC MARTENS ACM VREUGDENHIL G PILLAY M COX PH BIJSER M BRUTEL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., IL-6-INDUCED ANEMIA IN RATS - POSSIBLE PATHOGENETIC IMPLICATIONS FOR ANEMIA OBSERVED IN CHRONIC INFLAMMATIONS, Clinical and experimental immunology, 103(2), 1996, pp. 328-334
ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM WOGNUM A VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: M. Jongenlavrencic et al., ELEVATED LEVELS OF INFLAMMATORY CYTOKINES IN BONE-MARROW OF PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE, Arthritis and rheumatism, 39(9), 1996, pp. 1018-1018
COURSE AND CHARACTERISTICS OF ANEMIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS OF RECENT-ONSET
Authors: PEETERS HRM JONGENLAVRENCIC M RAJA AN RAMDIN HS VREUGDENHIL G BREEDVELD FC SWAAK AJG
Citation: Hrm. Peeters et al., COURSE AND CHARACTERISTICS OF ANEMIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS OF RECENT-ONSET, Annals of the Rheumatic Diseases, 55(3), 1996, pp. 162-168
EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND 52 WEEKS CLINICAL-TRIAL
Authors: PEETERS HRM JONGENLAVRENCIC M VREUGDENHIL G SWAAK AJG
Citation: Hrm. Peeters et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A RANDOMIZED PLACEBO-CONTROLLED DOUBLE-BLIND 52 WEEKS CLINICAL-TRIAL, Annals of the Rheumatic Diseases, 55(10), 1996, pp. 739-744
INTERACTION OF INFLAMMATORY CYTOKINES AND ERYTHROPOEITIN IN IRON-METABOLISM AND ERYRHROPOIESIS IN ANEMIA OF CHRONIC DISEASE
Authors: JONGENLAVRENCIC M PEETERS HRM VREUGDENHIL G SWAAK AJG
Citation: M. Jongenlavrencic et al., INTERACTION OF INFLAMMATORY CYTOKINES AND ERYTHROPOEITIN IN IRON-METABOLISM AND ERYRHROPOIESIS IN ANEMIA OF CHRONIC DISEASE, Clinical rheumatology, 14(5), 1995, pp. 519-525
EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A LONG-TERM PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL
Authors: RALPH H PEETERS M JONGENLAVRENCIC M VREUGDENHIL G BREEVELD FC SWAAK AJG
Citation: H. Ralph et al., EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON ANEMIA AND DISEASE-ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND ANEMIA OF CHRONIC DISEASE - A LONG-TERM PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL, Arthritis and rheumatism, 38(9), 1995, pp. 813-813
PHASE-II TRIAL WITH M-CAVE-CEC AS A SALVAGE CHEMOTHERAPEUTIC REGIMEN FOR EARLY RELAPSED OR PRIMARY REFRACTORY HODGKINS-DISEASE
Authors: VREUGDENHIL G JONGENLAVRENCIC M RAEMAEKERS JMM DEPAUW BE
Citation: G. Vreugdenhil et al., PHASE-II TRIAL WITH M-CAVE-CEC AS A SALVAGE CHEMOTHERAPEUTIC REGIMEN FOR EARLY RELAPSED OR PRIMARY REFRACTORY HODGKINS-DISEASE, Annals of hematology, 69(6), 1994, pp. 303-306
R-H-ERYTHROPOIETIN COUNTERACTS THE INHIBITION OF IN-VITRO ERYTHROPOIESIS BY TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH RHEUMATOID-ARTHRITIS
Authors: JONGENLAVRENCIC M PEETERS HRM BACKX B TOUW IP VREUGDENHIL G SWAAK AJG
Citation: M. Jongenlavrencic et al., R-H-ERYTHROPOIETIN COUNTERACTS THE INHIBITION OF IN-VITRO ERYTHROPOIESIS BY TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH RHEUMATOID-ARTHRITIS, Rheumatology international, 14(3), 1994, pp. 109-113
SERIAL ESTIMATION OF SERUM INTERLEUKIN-6 DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH THE ANEMIA OF RHEUMATOID-ARTHRITIS
Authors: JONGENLAVRENCIC M SWAAK AJG VREUGDENHIL G
Citation: M. Jongenlavrencic et al., SERIAL ESTIMATION OF SERUM INTERLEUKIN-6 DURING TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH THE ANEMIA OF RHEUMATOID-ARTHRITIS, Journal of rheumatology, 20(7), 1993, pp. 1253-1254
Risultati: 1-12 |